Lanfermeijer J, van de Ven K, van Dijken H, Hendriks M, Talavera Ormeno C, de Heij F
NPJ Vaccines. 2023; 8(1):116.
PMID: 37573454
PMC: 10423225.
DOI: 10.1038/s41541-023-00705-y.
Viboud C, Gostic K, Nelson M, Price G, Perofsky A, Sun K
PLoS Pathog. 2020; 16(9):e1008583.
PMID: 32970783
PMC: 7514029.
DOI: 10.1371/journal.ppat.1008583.
Lopez C, Legge K
Vaccines (Basel). 2020; 8(3).
PMID: 32756443
PMC: 7565301.
DOI: 10.3390/vaccines8030434.
Goncalves E, Bonduelle O, Soria A, Loulergue P, Rousseau A, Cachanado M
J Clin Invest. 2019; 129(5):1960-1971.
PMID: 30843873
PMC: 6486343.
DOI: 10.1172/JCI125372.
Tiger Li Z, Zarnitsyna V, Lowen A, Weissman D, Koelle K, Kohlmeier J
J Virol. 2019; 93(6).
PMID: 30626684
PMC: 6401462.
DOI: 10.1128/JVI.01534-18.
Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1 Epitope-Specific CD8 T Lymphocytes.
van de Sandt C, Pronk M, van Baalen C, Fouchier R, Rimmelzwaan G
J Virol. 2018; 92(11).
PMID: 29593036
PMC: 5952141.
DOI: 10.1128/JVI.00232-18.
Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition.
Woolthuis R, van Dorp C, Kesmir C, De Boer R, van Boven M
Sci Rep. 2016; 6:33334.
PMID: 27629812
PMC: 5024124.
DOI: 10.1038/srep33334.
Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
van de Sandt C, Kreijtz J, Geelhoed-Mieras M, Nieuwkoop N, Spronken M, van de Vijver D
J Virol. 2015; 90(2):1009-22.
PMID: 26537686
PMC: 4702701.
DOI: 10.1128/JVI.02439-15.
The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin.
Thyagarajan B, Bloom J
Elife. 2014; 3.
PMID: 25006036
PMC: 4109307.
DOI: 10.7554/eLife.03300.
Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
van de Sandt C, Kreijtz J, de Mutsert G, Geelhoed-Mieras M, Hillaire M, Vogelzang-van Trierum S
J Virol. 2013; 88(3):1684-93.
PMID: 24257602
PMC: 3911609.
DOI: 10.1128/JVI.02843-13.
Timing of pathogen adaptation to a multicomponent treatment.
Bourget R, Chaumont L, Sapoukhina N
PLoS One. 2013; 8(8):e71926.
PMID: 23991006
PMC: 3749216.
DOI: 10.1371/journal.pone.0071926.
Stability-mediated epistasis constrains the evolution of an influenza protein.
Gong L, Suchard M, Bloom J
Elife. 2013; 2:e00631.
PMID: 23682315
PMC: 3654441.
DOI: 10.7554/eLife.00631.
Evasion of influenza A viruses from innate and adaptive immune responses.
van de Sandt C, Kreijtz J, Rimmelzwaan G
Viruses. 2012; 4(9):1438-76.
PMID: 23170167
PMC: 3499814.
DOI: 10.3390/v4091438.
Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1.
Terajima M, Ennis F
J Virol. 2012; 86(18):10258.
PMID: 22923812
PMC: 3446634.
DOI: 10.1128/JVI.00894-12.
Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
Hillaire M, Osterhaus A, Rimmelzwaan G
J Biomed Biotechnol. 2011; 2011:939860.
PMID: 22007149
PMC: 3189652.
DOI: 10.1155/2011/939860.
Targets for the induction of protective immunity against influenza a viruses.
Bodewes R, Osterhaus A, Rimmelzwaan G
Viruses. 2011; 2(1):166-188.
PMID: 21994606
PMC: 3185556.
DOI: 10.3390/v2010166.
Phenotypic differences in viral immune escape explained by linking within-host dynamics to host-population immunity.
Pepin K, Volkov I, Banavar J, Wilke C, Grenfell B
J Theor Biol. 2010; 265(4):501-10.
PMID: 20570681
PMC: 4537168.
DOI: 10.1016/j.jtbi.2010.05.036.
Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
Tan P, Heiny A, Miotto O, Salmon J, Marques E, Lemonnier F
PLoS One. 2010; 5(1):e8754.
PMID: 20090904
PMC: 2807450.
DOI: 10.1371/journal.pone.0008754.
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.
Wahl A, McCoy 4th W, Schafer F, Bardet W, Buchli R, Fremont D
J Virol. 2009; 83(18):9206-14.
PMID: 19553306
PMC: 2738244.
DOI: 10.1128/JVI.00932-09.
Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.
Ng A, Zhang H, Tan K, Li Z, Liu J, Chan P
FASEB J. 2008; 22(10):3638-47.
PMID: 18614582
PMC: 2537428.
DOI: 10.1096/fj.08-112110.